Akero Therapeutics, Inc. reports

Company location: South San Francisco, CA
Fiscal year end: 31 December

Akero Therapeutics, Inc. has filed 734 SEC EDGAR filings since 18 Dec 2018

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 651-675 of 734 matching filings.

Per page

25

Current page

27

4

4

Filing date: 21 Jan 2020
Reporting date: 16 Jan 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 15 Jan 2020
Reporting date: 10 Jan 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A File 005-91047

SC 13D/A

Filing date: 15 Jan 2020
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 14 Jan 2020
Reporting date: 13 Jan 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38944

FORM 8-K

Filing date: 13 Jan 2020
Reporting date: 13 Jan 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 10 Jan 2020
Reporting date: 10 Jan 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 10 Jan 2020
Reporting date: 08 Jan 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 09 Jan 2020
Reporting date: 07 Jan 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 08 Jan 2020
Reporting date: 06 Jan 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 06 Jan 2020
Reporting date: 02 Jan 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 06 Jan 2020
Reporting date: 02 Jan 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 03 Jan 2020
Reporting date: 31 Dec 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 03 Jan 2020
Reporting date: 31 Dec 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 03 Jan 2020
Reporting date: 31 Dec 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 03 Jan 2020
Reporting date: 31 Dec 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 02 Jan 2020
Reporting date: 31 Dec 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4/A

4/A

Filing date: 31 Dec 2019
Reporting date: 27 Dec 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 31 Dec 2019
Reporting date: 27 Dec 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 31 Dec 2019
Reporting date: 30 Dec 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 26 Dec 2019
Reporting date: 20 Dec 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 19 Dec 2019
Reporting date: 17 Dec 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 19 Dec 2019
Reporting date: 17 Dec 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 13 Dec 2019
Reporting date: 13 Dec 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 13 Dec 2019
Reporting date: 13 Dec 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 13 Dec 2019
Reporting date: 13 Dec 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .